BUFFALO, N.Y., Oct. 21, 2013 /PRNewswire/ -- CTG (NASDAQ:
CTG), an information technology (IT) solutions and services
company, announced its financial results for the 2013 third quarter
which ended on September 27, 2013.
CTG also announced today that its Board of Directors approved a new
one million common share repurchase authorization.
"The highlight of third quarter results is an operating margin
of 6.0% for the second consecutive quarter, the highest level in
almost 15 years," said CTG Chairman and Chief Executive Officer
James R. Boldt. "The strength of our
margin is coming from disciplined expense control, which enabled us
to generate earnings that met guidance despite lower than expected
revenue."
"Our healthcare business declined from last year as a number of
hospital clients are holding off on system investments while they
determine how to adjust their cost structure to deal with lower
reimbursements as a result of the U.S. federal budget
sequestration. While the federal budget sequestration is
affecting revenue growth from healthcare providers in the short
term, we also know that hospitals must invest in EMR systems to
comply with health reform mandates and to lower costs in order to
remain competitive and financially viable in a rapidly changing
business environment. More recently we have seen a
significant increase in requests for proposals for healthcare
application outsourcings, which provide a way for hospitals to
reduce their operating costs without making significant financial
investments. Late in the quarter, we secured our first
European EMR advisory consulting project, an important first step
toward doing more significant full-scale EMR implementations as
European healthcare providers begin to adopt U.S. EMR software
packages to improve healthcare delivery and lower
costs."
"Further working to our benefit in the future growth of our
healthcare IT business is a strong reputation and standing in the
marketplace as reflected by CTG Health Solutions recently placing
seventh in the Modern Healthcare 2013 annual ranking of the
largest healthcare management consulting firms, three spots above
the 2012 survey. CTG Health Solutions was also named as a 2013
Modern Healthcare Best Place to Work in Healthcare which
enhances our ability to recruit experienced health IT consultants
in a highly competitive market for health IT talent."
2013 Third Quarter Review
Revenue, operating income, net income, and diluted net income
per share for the 2013 third quarter as compared with the 2012
third quarter were as follows (dollar amounts in thousands except
per-share data):
|
|
Sept. 27,
2013
|
|
|
Sept. 28,
2012
|
|
|
$
Change
|
|
%
Change
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
$
|
100,689
|
|
$
|
106,418
|
|
$
|
(5,729)
|
|
(5)%
|
Operating
income
|
$
|
6,054
|
|
$
|
6,323
|
|
$
|
(269)
|
|
(4)%
|
Net income
|
$
|
3,863
|
|
$
|
3,813
|
|
$
|
50
|
|
1%
|
Diluted net income
per share
|
$
|
0. 23
|
|
$
|
0.23
|
|
$
|
0.00
|
|
-
|
The Company's operating margin improved by 10 basis points to 6.0%
from 5.9% in the 2012 third quarter.
Solutions revenue in the 2013 third quarter was $40.0 million, representing 40% of total revenue
compared with 42% of total revenue in the 2012 third quarter.
Staffing revenue was $60.7 million,
or 60% of total revenue, compared with 58% of total revenue in the
2012 third quarter. European revenue increased 12% to
$18.2 million, or 18% of total
revenue, from $16.3 million, or 15%
of total revenue, in the 2012 third quarter. Foreign currency
exchange fluctuations had a $1.0
million favorable effect on revenue in the quarter compared
with the 2012 third quarter. The increase in revenue from
CTG's European operations is attributable to growth in its
financial services practice and the addition of etrinity, the
Belgium-based health IT services
provider acquired in February 2013. There were 63
billing days in the third quarter of 2013 and 2012.
Selling, general, and administrative (SG&A) expenses in the
2013 third quarter were $15.1
million, or 15% of revenue, a 10% decrease from $16.8 million, or 15.8% of revenue, in the 2012
third quarter.
Cash provided by operations was $3.0
million in the 2013 third quarter compared with cash
provided by operations of $6.2
million in the 2012 third quarter. At September 27, 2013, the Company had $31.5 million in cash compared with $29.4 million at the end of the 2012 third
quarter. The Company had no outstanding debt at the end of
the 2013 and 2012 third quarters. The tax rate for the
quarter was 35.2%.
2013 Year-to-date Review
Results for the first three quarters of the year reflect the
same trends seen in the third quarter. Revenue, operating
income, net income, and diluted net income per share for the first
three quarters of 2013 as compared with the first three quarters of
2012 are as follows (dollar amounts in thousands except per share
data):
|
|
Sept. 27,
2013
|
|
|
Sept.
28, 2012
|
|
|
$
Change
|
|
%
Change
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
$
|
316,301
|
|
$
|
316,490
|
|
$
|
(189)
|
|
-
|
Operating
income
|
$
|
18,635
|
|
$
|
18,065
|
|
$
|
570
|
|
3%
|
Net income
|
$
|
11,975
|
|
$
|
11,296
|
*
|
$
|
679
|
|
6%
|
Diluted net income
per share
|
$
|
.70
|
|
$
|
0.67
|
*
|
$
|
0.03
|
|
4%
|
*Includes the effect of one-time proceeds of $0.4 million, or 2 ½ cents per diluted share,
from life insurance proceeds paid to the Company in the 2012 second
quarter.
The Company's operating margin increased by 20 basis points to
5.9% in the first three quarters of 2013 from 5.7% in the same
period of 2012. For the first three quarters of 2013, CTG's
solutions business was $124.3
million, or 39% of total revenue, and its staffing business
was $192.0 million, or 61% of total
revenue. European revenue in the first three quarters of 2013
increased 12% to $56.2 million, or
18% of total revenue, compared with $50.3
million or 16% of total revenue in the comparable 2012
period.
Selling, general, and administrative expenses were $47.8 million, or 15.1% of revenue, a decrease of
$2.0 million or 4% from $49.8 million, or 15.7% of revenue, in the first
three quarters of 2012.
Stock Repurchase Program
CTG repurchased 225,000 of its shares in the 2013 third quarter
at an average price of $18.41 per
share. In October 2013, the
Company extended its 10b5-1 stock repurchase plan to facilitate the
repurchase of its common stock during its self-imposed blackout
periods prior to the announcement of quarterly results.
Including the new one million share repurchase authorization
announced today, approximately 1.2 million shares are currently
available for repurchase.
Mr. Boldt commented, "Our Board's new one million share
repurchase authorization reflects the company's strong financial
position and our continued confidence in CTG's future
prospects. In addition to our active share repurchase
program, our commitment to delivering shareholder value is also
reflected in our adoption earlier this year of a regular quarterly
cash dividend."
2013 Fourth Quarter and Full Year Guidance
CTG is providing guidance for the 2013 fourth quarter and full
year in the table below. Based on year-to-date results and
trends in its business, the Company has set guidance for the 2013
fourth quarter and adjusted its range of revenue and earnings
guidance for the 2013 full year from previous guidance to reflect a
reduction in the demand for resources on hospital EMR projects and
for resource levels currently needed by a large staffing
client.
2013 Fourth
Quarter (65 billing days vs. 64 in Q4 2012)
|
Range
|
Range
midpoint
|
Change from 2012
fourth
quarter at range
midpoint*
|
Revenue
|
$104-$106
million
|
$105
million
|
- 2.7%
|
Diluted net income
per share *
|
$0.22 -
$0.24
|
$0.23
|
- 4.2%
|
*Comparison to 2012 excludes the effect of non-operational gains
of $0.8 million, or 5 cents per diluted share, from life insurance
proceeds received by the Company in the 2012 fourth quarter
2013 Full Year
(Projected tax rate of 35% to 37%)
|
Range
|
Range
midpoint
|
Change from
2012
at range
midpoint**
|
Revenue
|
$420-$422
million
|
$421
million
|
- 0.8%
|
Diluted net income
per share **
|
$0.93 -
$0.95
|
$0.94
|
+ 6.8%
|
**Comparison to 2012 excludes the effect of non-operational
gains of $1.3 million, or 7 ½ cents
per diluted share, from life insurance proceeds received by the
Company in 2012
Mr. Boldt commented, "Although we are projecting revenue to
decrease slightly compared to last year, we still expect earnings
and margin growth for the full year, which is a solid performance
given that overall spending in the IT services industry is
constrained in 2013. Importantly, with the focus on our
healthcare business and disciplined expense control, CTG continues
to become a more profitable company with our operating margin
moving into our strategic goal range of six to seven percent in the
last two quarters despite some of the revenue challenges we are
experiencing this year."
Mr. Boldt concluded, "CTG's robust offerings in EMR as well as
other areas such as post-implementation EMR production support,
application management outsourcing, and medical data analytics, all
support cost and risk reduction for healthcare organizations. We
are also continuing to grow our payer business and see strong
potential there in our IT medical management model and our fraud,
waste, and abuse software. With European countries just
starting to implement U.S. EMR systems, CTG is very well positioned
to capitalize on this major multi-year opportunity based on our
significant U.S. EMR implementation experience and a large
established European presence that includes etrinity, the health IT
services firm we acquired earlier this year. This breadth of
growth opportunity from multiple sources gives us great confidence
that we will be able to continue building our healthcare IT
business and advance CTG's transformation to an IT services and
solutions company with a focus on healthcare
IT."
About CTG
CTG develops innovative IT solutions to address the business
needs and challenges of companies in several higher-growth
industries including healthcare, technology services, energy, and
financial services. As a leading provider of IT and business
consulting services to the healthcare market, CTG offers healthcare
institutions, physician practices, payers, and related
organizations a full range of offerings to help them achieve
clinical, operational, and financial goals. CTG has developed
for the healthcare provider and payer markets unique, proprietary
software solutions that support better and lower cost
healthcare. CTG also provides managed services IT staffing
for major technology companies and large corporations. Backed
by over 45 years' experience, proprietary methodologies, and an ISO
9001-certified management system, CTG has a proven track record of
delivering high-value, industry-specific solutions. CTG
operates in North America and
Western Europe. CTG posts news and other important
information on the Web at www.ctg.com.
Safe Harbor Statement
This document contains certain forward-looking statements
concerning the Company's current expectations as to future growth.
These statements are based upon a review of industry reports,
current business conditions in the areas where the Company does
business, the availability of qualified professional staff, the
demand for the Company's services, and other factors that involve
risk and uncertainty. As such, actual results may differ materially
in response to a change in such factors. Such forward-looking
statements should be read in conjunction with the Company's
disclosures set forth in the Company's 2012 Form 10-K, which is
incorporated by reference. The Company assumes no obligation to
update the forward-looking information contained in this
release.
Conference Call and Webcast
CTG will hold a conference call to discuss its financial results
and business strategy on Tuesday, October
22, 2013 at 10:00 a.m. Eastern
Time. CTG Chairman and Chief Executive Officer
James R. Boldt will lead the
call. Interested parties can dial in to 1-888-276-0010
between 9:45 a.m. Eastern Daylight
Time (EDT) and 9:50 a.m. EDT
and ask for the CTG conference call. A replay of the call
will be available between 12:00 p.m.
EDT October 22, 2013 and
11:00 p.m. EDT October 25, 2013 by dialing 1-800-475-6701 and
entering the conference ID number 269075.
A webcast of the call will be available on CTG's web site:
http://www.ctg.com. The webcast will also be archived on CTG's
web site at http://investor.ctg.com/events.cfm for 90
days following completion of the conference call.
Financial statements follow.
COMPUTER TASK
GROUP, INCORPORATED (CTG) Condensed Consolidated Statements
of Income
(Unaudited)
(amounts in thousands except per share data)
|
|
|
|
|
|
|
|
|
|
For the Quarter
Ended
|
|
For the Three
Quarters Ended
|
|
|
|
Sept.
27,
|
|
Sept
28,
|
|
Sept.
27,
|
|
Sept.
28,
|
|
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
100,689
|
|
$
|
106,418
|
|
$
|
316,301
|
|
$
|
316,490
|
Direct
costs
|
|
|
79,506
|
|
|
83,283
|
|
|
249,872
|
|
|
248,608
|
Selling, general and
administrative expenses
|
|
15,129
|
|
|
16,812
|
|
|
47,794
|
|
|
49,817
|
Operating
income
|
|
|
6,054
|
|
|
6,323
|
|
|
18,635
|
|
|
18,065
|
Non-taxable life
insurance proceeds
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
423
|
Other expense,
net
|
|
|
(91)
|
|
|
(68)
|
|
|
(306)
|
|
|
(157)
|
Income before income
taxes
|
|
|
5,963
|
|
|
6,255
|
|
|
18,329
|
|
|
18,331
|
Provision for income
taxes
|
|
|
2,100
|
|
|
2,442
|
|
|
6,354
|
|
|
7,035
|
Net income
|
|
$
|
3,863
|
|
$
|
3,813
|
|
$
|
11,975
|
|
$
|
11,296
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per
share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.25
|
|
$
|
0.25
|
|
$
|
0.78
|
|
$
|
0.75
|
|
Diluted
|
|
$
|
0.23
|
|
$
|
0.23
|
|
$
|
0.70
|
|
$
|
0.67
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
15,356
|
|
|
15,075
|
|
|
15,415
|
|
|
15,123
|
|
Diluted
|
|
|
16,923
|
|
|
16,800
|
|
|
17,029
|
|
|
16,807
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividend
declared per share
|
|
|
$
0.05
|
|
|
$
-
|
|
|
$
0.15
|
|
|
$
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPUTER TASK
GROUP, INCORPORATED (CTG)
Condensed Consolidated Balance Sheets
(Unaudited)
(amounts in
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
September
27,
|
|
December
31,
|
|
September
28,
|
|
|
|
2013
|
|
2012
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
Current
Assets:
|
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
31,532
|
|
$
|
40,614
|
|
$
|
29,412
|
|
Accounts receivable,
net
|
|
|
75,242
|
|
|
70,459
|
|
|
70,600
|
|
Other current
assets
|
|
|
3,304
|
|
|
2,595
|
|
|
3,292
|
Total current
assets
|
|
|
110,078
|
|
|
113,668
|
|
|
103,304
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and
equipment, net
|
|
|
7,837
|
|
|
6,916
|
|
|
7,061
|
|
Goodwill
|
|
|
37,999
|
|
|
35,678
|
|
|
35,678
|
|
Other
assets
|
|
|
11,898
|
|
|
9,943
|
|
|
9,545
|
|
|
|
|
|
|
|
|
|
|
|
Total
Assets
|
|
$
|
167,812
|
|
$
|
166,205
|
|
$
|
155,588
|
|
|
|
|
|
|
|
|
|
|
|
Current
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
9,976
|
|
$
|
10,170
|
|
$
|
9,593
|
|
Accrued
compensation
|
|
|
28,222
|
|
|
32,162
|
|
|
29,943
|
|
Other current
liabilities
|
|
|
6,295
|
|
|
7,869
|
|
|
6,272
|
Total current
liabilities
|
|
|
44,493
|
|
|
50,201
|
|
|
45,808
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term
debt
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Other
liabilities
|
|
|
13,109
|
|
|
13,223
|
|
|
10,427
|
|
Shareholders'
equity
|
|
|
110,210
|
|
|
102,781
|
|
|
99,353
|
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities and
Shareholders' Equity
|
|
$
|
167,812
|
|
$
|
166,205
|
|
$
|
155,588
|
|
|
|
|
|
|
|
|
|
|
|
COMPUTER TASK
GROUP, INCORPORATED (CTG) Condensed Consolidated Statements
of Cash Flows
(Unaudited)
(amounts in thousands)
|
|
|
|
|
|
|
|
For the Three
Quarters Ended
|
|
|
|
September
27,
|
|
September
28,
|
|
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
11,975
|
|
$
|
11,296
|
|
Depreciation and
amortization expense
|
|
|
1,976
|
|
|
1,976
|
|
Equity-based
compensation expense
|
|
|
1,914
|
|
|
1,595
|
|
Other operating
items
|
|
|
(15,050)
|
|
|
(5,109)
|
Net cash provided by
operating activities
|
|
|
815
|
|
|
9,758
|
Net cash used in
investing activities
|
|
|
(5,607)
|
|
|
(1,202)
|
Net cash used in
financing activities
|
|
|
(4,433)
|
|
|
(1,510)
|
Effect of exchange
rates on cash and cash equivalents
|
|
|
143
|
|
|
(48)
|
Net increase
(decrease) in cash and cash equivalents
|
|
|
(9,082)
|
|
|
6,998
|
Cash and cash
equivalents at beginning of period
|
|
|
40,614
|
|
|
22,414
|
Cash and cash
equivalents at end of period
|
|
$
|
31,532
|
|
$
|
29,412
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ctg-e
SOURCE CTG